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The cholinergic contribution to the 
resting-state functional network in 
non-demented Parkinson’s disease
Yoonju Lee1, Jee Hyun Ham1, Jungho Cha2, Yeong-Hun Park3, Jae Jung Lee4,  
Mun Kyung Sunwoo5, Jin Yong Hong6, Young H. Sohn1, Jong-Min Lee3 & Phil Hyu Lee1,7
The cholinergic system arising from the basal forebrain plays an important role in cognitive 
performance in Parkinson’s disease (PD). Here, we analyzed cholinergic status-dependent cortical 
and subcortical resting-state functional connectivity in PD. A total of 61 drug-naïve PD patients were 
divided into tertiles based on normalized substantia innominata (SI) volumes. We compared the resting-
state network from seed region of interest in the caudate, posterior cingulate cortex (PCC), and SI 
between the lowest (PD-L) and highest tertile (PD-H) groups. Correlation analysis of the functional 
networks was also performed in all subjects. The functional network analysis showed that PD-L subjects 
displayed decreased striato-cortical functional connectivity compared with PD-H subjects. Selecting 
the PCC as a seed, the PD-L patients displayed decreased functional connectivity compared to PD-H 
patients. Meanwhile, PD-L subjects had significantly increased cortical functional connectivity with the 
SI compared with PD-H subjects. Correlation analysis revealed that SI volume had a positive correlation 
with functional connectivity from the right caudate and PCC. The present study demonstrated that PD 
patients exhibited unique functional connectivity from the caudate and the PCC that may be closely 
associated with cholinergic status, suggesting an important role for the cholinergic system in PD-
associated cognition.
Cognitive impairment, as one of the most disabling non-motor features, is known to occur in the early stages of 
PD1. Although the neural basis of cognitive dysfunction in PD remains unknown, pathological and functional 
neuroimaging studies suggest that the cholinergic system arising from the basal forebrain plays an important role 
in cognitive performance. According to a staging study of PD pathology, α-synuclein-positive inclusions in the 
basal cholinergic forebrain areas simultaneously occur with nigral pathology in the early stage of PD2. Similarly, a 
recent in vivo positron emission tomography (PET) study of cerebral acetylcholinesterase demonstrated that cho-
linergic dysfunction occurs in the early course of PD and is more widespread and profound in the development 
of PDD3,4. Furthermore, our recent volumetric magnetic resonance imaging (MRI) analysis demonstrated that 
volume loss in the substantia innominata (SI), the major source of cholinergic input, occurs in cognitively normal 
patients with PD and is most profound in patients with PDD5. Moreover, we demonstrated that SI volume is an 
important factor in predicting the future development of cognitive decline6.
Resting-state networks (RSN) are associated with self-oriented mental activity and offer a means of evaluat-
ing the status of functional systems within the brain without externally goal-directed cognitive performance7. 
Furthermore, altered RSN is known to be associated with cognitive status in Alzheimer’s disease and dementia 
with Lewy bodies in addition to PD8,9. Therefore, RSN analysis may be helpful in the identification of brain 
regions functionally coupled with pathological change-dependent processes in neurodegenerative disease. 
Besides underlying pathological changes, the pattern of RSN is also influenced by several factors, such as var-
ious neurochemicals10. In terms of cholinergic system, the identification of specific functional network maps 
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that are closely related with cholinergic system never been studied, although this approach would inform our 
basic understanding about cholinergic influence on cognitive performance in patients with PD. In the pres-
ent study, we hypothesized that changes in the cholinergic system would influence the functional connectivity 
pattern in patients with PD. Thus, we performed a comparative analysis of RSN according to the SI volume in 
non-demented drug naïve PD patients to further elucidate cholinergic system-dependent cortical-subcortical 
functional networks.
Results
Demographic characteristics. The demographic features of the PD and control groups are presented in 
Table 1. No significant differences in age, gender, disease duration, education duration, UPDRS III score, the 
K-MMSE score, CCSI score, BDI score, or motor subtype were observed between the PD-L and PD-H groups. In 
addition, DAT activity in the posterior putamen did not differ significantly between the PD-L and PD-H groups. 
The mean total brain volume did not differ significantly among the PD-L, PD-H, and control groups (1,292,237.80 
vs. 1,282,358.10 vs. 1,261,833.67 vs 1,258,427.86). As expected, the normalized SI volume was smaller in the PD-L 
group (1.20) compared with the PD-H (1.65) and control groups (1.66, P < 0.001). Of 61 patients with PD, 11 
patients had normal cognition and 50 had mild cognitive impairment (MCI). The detailed neuropsychological 
test showed no significant differences in all cognitive tests between the PD-L and PD-H groups (Supplementary 
Table S1). The number of patients complaining of depression, anxiety, apathy, or sleep disorder did not differ 
significantly (Supplementary Table S1) between the PD-L and PD-H groups.
Comparative analysis of resting-state striato-cortical connectivity from the seed ROI in the 
caudate. When the right caudate nucleus was selected as a seed, PD-H showed decreased functional con-
nectivity compared with controls in the frontal areas, parietal area, temporal areas, precentral area, posterior 
cingulate area, and cerebellar areas (Fig. 1A). Similarly, PD-L showed decreased functional connectivity in frontal 
areas, parietal area, temporal areas, fusiform and posterior cingulate areas, and cerebellar areas relative to controls 
(Fig. 1B). In a direct comparison of the two groups, PD-L displayed decreased functional connectivity with the 
prefrontal areas, primary motor areas, posterior cingulate area, and cerebellar areas relative to PD-H (Fig. 1C). 
No areas of increased cortical functional connectivity were found in the PD-L group relative to the PD-H group. 
Additionally, using the left caudate as a seed for the RSN analysis, PD-H exhibited decreased striato-cortical func-
tional connectivity compared with normal controls in the postcentral area, parietal area, prefrontal and anterior 
cingulate areas, temporal areas, fusiform areas, and cerebellar areas (Supplementary Fig. 1A). Similarly, PD-L 
showed decreased functional connectivity in the postcentral and parietal areas, prefrontal areas, anterior and 
posterior cingulate, temporal areas, fusiform areas, and cerebellar areas (Supplementary Fig. 1B). In a direct 
comparison, the PD-L group exhibited decreased striato-cortical functional connectivity in the frontal areas, 
inferior temporal area, middle and posterior cingulate areas, and cerebellar areas compared with the PD-H group 
(Supplementary Fig. 1C). No areas of increased cortical RSN were observed in the PD-L group relative to the 
PD N: 61 PD-L N: 20 PD-H N: 21 Control N: 29 p-value
Age (year) 69.2 (6.3) 70.9 (4.4) 68.6 (6.1) 71.2 (5.2) NS
Gender (male, %) 30 (49.2) 11 (55.0) 8 (38.1) 9 (32.1) NS
Parkinsonism duration, years 2.9 (2.8) 3.1 (2.4) 2.7 (2.0) — NS
Education years 9.1 (4.7) 10.0 (5.0) 8.5 (4.8) 10.2 (6.2) NS
UPDRS III 26.7 (9.5) 25.16 (9.0) 26.1 (8.4) — NS
K-MMSE 26.3 (2.3) 26.7 (2.4) 25.8 (2.1) 28.3(1.4)* 0.001
CCSI 6.0 (2.2) 6.1 (1.7) 6.1 (2.4) 10.3 (1.5)* <0.001
BDI 15.9 (10.1) 14.9 (8.7) 15.5 (10.6) 12.6 (9.5) NS
PD motor subtype (%)
   Tremor-dominant 32.8 30 28.6 —
NS   PIGD 39.3 35 42.9 —
   Mixed 27.9 35 28.6 —
DAT activity
   More affected side† 0.93 (0.23) 0.93 (0.25) 0.99 (0.28) NS
   Less affected side 1.34 (0.45) 1.47 (0.44) 1.42 (0.57) NS
Total brain volume, mm3 1278531.57(110503.17)
1292237.80
(120894.66)
1261833.67
(115168.27)
1258427.86
(109816.53) NS
Normalized SI volume 1.43 (0.21) 1.20(0.08)‡ 1.65(0.13) 1.66(0.11) <0.001
Table 1. Demographic characteristics of Parkinson’s disease (PD) according to substantia innominate (SI) 
volume. Values are expressed as mean (±standard deviation) or number of subjects (%). PD-S, PD with smaller 
SI volume group; PD-L, PD with larger SI volume group; UPDRS, unified Parkinson’s disease rating scale; 
K-MMSE, Korea version of the Mini-Mental State Examination; CCSI, Cross-Cultural Smell Identification; 
BDI, Beck Depression Inventory; PIGD, Postural instability/gait difficulty; DAT, Dopamine transporter; NS, 
not significant. †A site where a within-subject DAT activity in the posterior putamen of one hemisphere is lower 
relative to the other hemisphere. *Control vs PD-L or PD-H (Bonferroni corrected p-value). ‡PD-S vs PD-L or 
control (Bonferroni corrected p-value).
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PD-H group. The anatomical locations of the significant peaks based on the seed ROI in seed region are listed in 
Supplementary Tables S2 and S3.
Comparative analysis of cortico-cortical functional connectivity from the seed ROI in the 
PCC. Compared with the control group, the PD-H group showed decreased functional connectivity with the 
PCC in the primary motor and sensory areas, precuneus, and occipital areas (Fig. 2A). PD-L showed decreased 
functional connectivity in the precuneus and occipital areas (Fig. 2B). No areas of increased cortical RSN were 
observed in the PD-H or PD-L groups compared to the control group. In a direct comparison, the PD-L group 
displayed decreased functional connectivity with the prefrontal areas, inferior temporal areas, and parietal 
areas compared with the PD-H group (Fig. 2C). The anatomical locations of the significant peaks are listed in 
Supplementary Table S4.
Comparative analysis of cortical and subcortical functional connectivity from the seed ROI in 
the SI. Relative to the control group, both the PD-L and PD-H groups had increased cortical functional con-
nectivity with the SI in the prefrontal, posterior cortical, and cerebellar areas; unexpectedly, the area of increased 
cortical RSN with the SI was more widespread in PD-L than in PD-H (Fig. 3A). No areas of decreased cortical or 
subcortical connectivity were observed in the PD-L or PD-H groups compared to the control group. In the direct 
comparison, the PD-L group exhibited increased cortical RSN in the parietal area relative to the PD-H group 
(Fig. 3B). The anatomical locations of the significant peaks are listed in Supplementary Table S5.
Correlation analysis of the SI volume and resting state functional connectivity. The SI vol-
ume was positively correlated with functional network from the right caudate in the frontal and temporal areas 
(Fig. 4A). However, there were no significant areas in which the SI volume was positively or negatively correlated 
with cortical RSN from the left caudate nucleus. Using the PCC as a seed for the RSN analysis, the functional 
connectivity was positively correlated with the SI volume in the inferior temporal, prefrontal, and cuneus areas 
(Fig. 4B). The anatomical locations of the significant peaks are listed in Supplementary Table S6.
Correlation analysis of the cognitive total composite score and resting state functional con-
nectivity. Cognitive composite score was positively correlated with functional connectivity from the right 
caudate in the left parietal area (Supplementary Fig. 2A) and from the left caudate in the bilateral parietal areas 
Figure 1. Comparison of functional connectivity from the right caudate nucleus. Functional connectivity in 
patients with PD-H (A) and PD-L (B) was compared with that of control subjects. In a direct comparison of 
the two groups, the PD-L group displayed decreased functional connectivity with the right prefrontal areas, left 
inferior temporal areas and bilateral cerebellar areas relative to the PD-H group (C).
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(Supplementary Fig. 2B). Using the PCC as a seed, the functional connectivity was positively correlated with 
cognitive composite score in the bilateral parietal and temporal areas (Supplementary Fig. 2C). Additionally, 
cognitive composite score had a positive correlation with functional connectivity from SI seed in right prefrontal 
and bilateral occipital areas (Supplementary Fig. 2D). The anatomical locations of the significant peaks are listed 
in Supplementary Table S7.
Discussion
The present study demonstrates that even though cognitive performance is comparable, the RSN pattern would 
differ depending on the SI volume in non-demented PD subjects. First, the PD-L group showed decreased 
striato-cortical functional connectivity between the caudate and anterior prefrontal areas, posterior cortical areas 
and cerebellum relative to the PD-H group. Second, the PD-L group had decreased cortical functional connectiv-
ity with the PCC in the bilateral prefrontal, right inferior temporal and posterior cortical areas. Third, the PD-L 
group had increased cortical functional connectivity with the SI in the right parietal area compared to the PD-H 
group. Fourth, the SI volume was positively correlated with cortical RSN from the PCC and the caudate. The 
results of the present study indicate that resting state functional network might be closely coupled with the status 
of the cholinergic system in non-demented PD.
The SI of the basal forebrain contains the nucleus basalis of Meynert, which is the major source of cholinergic 
input to the cerebral cortex, and degeneration of the basal forebrain may represent a decline of cholinergic activity 
in the cerebral cortex. Generally, cholinergic inputs from the basal forebrain play a key role in attention, perfor-
mance on frontal lobe dependent tests, and memory function through their connections with frontal or basolat-
eral limbic areas11,12. More importantly, reduced cholinergic activity in the cortex secondary to degeneration of 
the SI constitutes an important mechanism underpinning cognitive dysfunction as well as a key player predicting 
the future development of cognitive decline in PD5,13.
The PCC, as a central region in the DMN, has functional connectivity with widespread cortical areas such as 
the medial prefrontal, dorsolateral prefrontal, inferior parietal, and temporal areas; thus, functional network from 
the PCC is associated with cognitive processes such as memory, attention, and spatial performance14. In patients 
with PD, a recent study reported that RSN within the DMN was altered and this abnormality was significantly 
associated with cognitive performance such as memory and visuospatial skills15. In addition, distinctive RSN 
patterns from the PCC seem to be dependent on cognitive status: the functional connectivity of the prefrontal 
area is attenuated in patients with PDD compared with cognitively normal PD patients9,16. In the present study, 
Figure 2. Comparison of cortico-cortical functional connectivity from the posterior cingulate cortex. 
Functional connectivity in patients with PD-H (A) and PD-L (B) was compared with that of control subjects. In 
a direct comparison, the PD group showed decreased functional connectivity with the bilateral prefrontal areas, 
right inferior temporal areas and posterior cortical areas (C).
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Figure 3. Comparison of cortico-cortical functional connectivity from the substantia innominata. Functional 
connectivity in patients with PD-H (A) and PD-L (B) was compared with that of control subjects. In a direct 
comparison, the PD-L patients had significantly increased cortical functional connectivity mainly in the right 
temporo-parietal areas compared with PD-H patients (C).
Figure 4. Correlation analysis of the substantia innominate volume and resting state functional connectivity. 
The SI volume was positively correlated with functional connectivity from the right caudate in the bilateral 
frontal and left temporal areas (A). Using the PCC as a seed, functional connectivity was positively correlated 
with the SI volume in the right inferior temporal, right prefrontal, and cuneus areas (B).
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we found decreased functional connectivity with the PCC in either the PD-L or PD-H group compared to control 
group. In a direct comparison, the PD-L group had decreased cortical functional connectivity in the bilateral 
prefrontal, right inferior temporal and posterior cortical areas relative to the PD-H group. Moreover, the SI vol-
ume was positively correlated with cortical functional connectivity with the PCC in the right inferior temporal, 
right prefrontal areas and cuneus areas. Accordingly, the present study provides evidence with regard to RSN, 
suggesting that PD-L patients have altered cortical RSN with the PCC in the early stages of PD prior to the decline 
of cognitive performance. This may explain why the status of the cholinergic nucleus acts as a prognostic marker 
of dementia conversion in PD.
The caudate nucleus, particularly the dorsal caudate, is part of the dorsolateral prefrontal circuit and thus, 
the caudate is involved in cognitive processes such as executive function, memory and attention. An association 
between the caudate nucleus and cognitive decline is also evident in patients with PD6,17. Regarding RSN between 
the striatum and cortex, the caudate is functionally coupled with prefrontal, parietotemporal, and cerebellar cor-
tices18. Patients with PD show decreased resting-state functional connectivity between the caudate and cortex rel-
ative to healthy controls; this is particularly evident in the frontal cortex, involving prefrontal, frontomedial, and 
orbitofrontal areas19, even though this caudate-cortical functional connectivity is not consistent20. In the present 
study, RSN analysis with the caudate seed revealed that PD-L patients had decreased functional connectivity in 
anterior prefrontal areas, posterior cortical areas and cerebellum compared with PD-H patients. Additionally, 
correlation analysis demonstrated that cortical functional connectivity with the caudate was positively associated 
with SI volume in the prefrontal areas. Therefore, the cholinergic nucleus seems to closely modulate cortical func-
tional connectivity with the caudate in patients with PD, further indicating the role of the cholinergic nucleus in 
PD-related cognitive dysfunction.
Interestingly, the present study also demonstrated that patients with PD had decreased functional connec-
tivity in the cerebellar areas from the caudate nucleus as SI volume became smaller. Functional connectivity 
between the striatum and cerebellum is well documented in healthy subjects as well as in patients with PD. 
This striato-cerebellar connectivity appears to be largely influenced by dopaminergic status, as this connectiv-
ity is markedly decreased in patients with PD21, and exogenous levodopa administration would enhance the 
striato-cerebellar functional connection in both healthy subjects and PD patients18,22. However, in the present 
study, the decreased striato-cerebellar functional connectivity in PD patients is difficult to explain based on neu-
rochemical changes in dopamine levels, as the severity of parkinsonian motor deficits assessed by the UPDRS 
motor score and DAT uptake was comparable between patients with PD-L and PD-H. This suggests that cho-
linergic status may also influence resting-status striato-cerebellar functional connectivity. According to recent 
studies, this striatocerebellar functional connectivity represents a major subcortical network that influences cog-
nitive processes in addition to movement. Specially, the cerebellum is known to participate in the adaptive mod-
ification of behavior and error-based learning23,24. Therefore, further research is required to clarify the specific 
types of cognitive dysfunction modulated by the striatocerebellar functional interconnections via cholinergic 
intervention.
According to a recent RSN analysis, the SI exhibited functional connectivity with widespread cortical areas, 
including the prefrontal, orbitofrontal, temporal, and posterior cortical areas, as well as subcortical areas, such 
as the basal ganglia, thalamus, midbrain, and cerebellum25. In the present study, the RSN analysis from the SI 
seed revealed that the PD-L group had increased cortical functional connectivity in right temporo-parietal areas 
relative to the PD-H group in contrast to RSN patterns observed in PCC seed. This pattern was similarly observed 
in the comparative RSN analysis with controls: both PD-L and PD-H patients had increased cortical RSN with 
the SI, however, the area was more extensive in patients with PD-L than in those with PD-H. It is possible that the 
enhanced functional connectivity in PD-L patients may be a compensatory process that maintains cholinergic 
nucleus-dependent cognitive performance in PD. Nevertheless, a further study of serial changes in RSN patterns 
from the SI after cholinergic modulation is required to uncover this issue.
There are several limitations of this study. First, even though this study enrolled drug-naïve de novo PD 
patients to exclude as much of the effect of dopaminergic medications on RSN as possible, the number of subjects 
in each group was relatively small to draw firm conclusions. Second, several factors that are commonly encoun-
tered in patients with PD such as olfactory dysfunction or depression may influence the pattern of RSN26,27. The 
CCSI and BDI scores were comparable between the groups, however, we could not completely exclude the impact 
of these factors on RSN patterns. Finally, the cortical and subcortical seeds used in the present study may not 
represent a complete functional connectivity analysis, and further study using other imaging analytic tools is 
required to explain the functional network maps.
In summary, the present study demonstrated that patients with PD exhibited unique resting-state functional 
connectivity from the caudate and the PCC that may be closely associated with cholinergic status. The identi-
fication of cholinergic status-dependent RSN may advance the current understanding of PD pathophysiology 
with respect to cognition, which may have an important impact on future trials of cognitive modulation in 
non-demented stage of PD.
Methods
Subjects. Sixty-one patients with non-demented PD and 29 normal healthy controls were sequentially 
enrolled between September 2011 and December 2014 from a movement clinic at a university hospital. All 
patients fulfilled the criteria for PD as proposed by the UK PD Society Brain Bank28 and exhibited reduced dopa-
mine transporter uptake in the posterior putamen on a [18F] FP-CIT PET scan. Parkinsonian motor symptoms 
were evaluated by the Unified PD Rating Scale Part III (UPDRS- III). We calculated a “tremor score” and a “pos-
tural instability/gait difficulty (PIGD) score” for each patient as described previously29 and classified patients into 
three clinical subtypes: tremor dominant, PIGD, and mixed. Olfactory function was assessed using a cross-cul-
tural smell identification (CCSI) test30, which has been widely used to evaluate the odor identification of PD 
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patients in many countries31. Exclusion criteria included presence of probable PD dementia32, obvious tremor that 
would cause motion related artifact for functional MRI analysis, structural lesions on brain MRI, Parkinsonian 
plus syndromes, a history of using drugs that can cause parkinsonism (antipsychotics, gastrointestinal kinetics, 
antiepileptic drugs, or L-type calcium channel blockers), or depression (a score >21 on the Beck Depression 
Inventory (BDI)). The Seoul Neuropsychological Screening Battery was used to evaluate detailed cognitive per-
formance. This battery includes the following scored tests: Digit Span test (forward and backward), the Korean 
version of the Boston Naming Test, Rey Complex Figure Test (copying, immediate and 20-min delayed recall, and 
recognition), drawing an interlocking pentagon, Seoul Verbal Learning Test (immediate recall, 20-min delayed 
recall, and recognition), phonemic and semantic Controlled Oral Word Association Test, go-no-go test and con-
trasting program, and Stroop Test (word and color reading of 112 items during a 2-min period)6. A diagnosis of 
PD-MCI was made based on the criteria suggested by the Movement Disorder Society Task Force guidelines33. 
Psychopathology (depression, anxiety, apathy or sleep disorder) was assessed using the Korean version of neu-
ropsychiatric inventory performed at the first visit34. The control group had no history of neurological disorders 
and no cognitive complaints with a minimal score on the Korean version of the Mini Mental State Examination 
(K-MMSE) of 27.
MR imaging analysis. Image acquisition. The study subjects performed functional MRI scanning using 
a 3.0 Tesla MRI scanner (Achieva, Philips Medical System, Best, Netherlands). A high-resolution T1-weighted 
MRI volume data set was obtained from all subjects using 3D T1-TFE sequence configured with the following 
acquisition parameters: axial acquisition with a 224 × 256 matrix; 256 × 256 reconstructed matrix with 182 slices 
in the coronal plane; 1-mm-thick sections; 220-mm field of view; 0.98 × 0.98 × 1.2 mm3 voxels; TE, 4.6 ms; TR, 
9.6 ms; flip angle, 8°; slice gap, 0 mm. To obtain T2*-weighted single shot echo planar imaging sequences, each 
participant was axially scanned using the following parameters: voxel size, 2.8 × 2.8 × 3.0 mm3; slice number, 31 
(interleaved); matrix, 80 × 80; slice thickness, 3.0 mm; gap, 1.0 mm; repetition time (TR), 2,000 ms; echo time 
(TE), 30 ms; flip angle = 90°; and field of view, 220 mm. Each 330-sec scan produced 165 functional MRI images, 
which is known to be enough to assess resting- state functional connectivity35 and to obtain low-frequency oscil-
lations for resting-state functional connectivity. During the functional MR imaging, subjects were instructed to 
remain awake with their eyes closed and to not move or focus on a specific thought.
Volumetric determination of the SI. The analysis was done using Statistical Parametric Mapping software (SPM8, 
Wellcome Department of Imaging Neuroscience, London, UK, available at http://www.fil.ion.ucl.ac.uk/spm). 
Each structural MRI was bias-corrected, segmented into SPM default tissue probability maps, and then nor-
malized with VBM8 DARTEL templates for registration to MNI space, using linear (12-parameter affine) and 
non-linear transformations within a unified model. According to the previous study36, the region of interest (ROI) 
of SI was defined one for the left and the other for the right hemisphere, based on the location of the anterior com-
missure, which forms the boundary of the superior part of the end of the anterior third of the substantia innom-
inata. The ROI extended 25 mm lateral from the midline, 13 mm ventral from the superior edge of the anterior 
commissure at the midline, and 3 mm anterior and 9 mm posterior from the middle of the anterior commissure. 
The masks were created using the WFU PickAtlas 2.4 software36, and volumetry of grey matter within selected 
ROI was done automatically. To correct for individual brain size, volumes were normalized by dividing with total 
brain volume derived from the masks covering entire brain. Normalized SI volume was defined by the following 
formula: total SI volume (mm3)/total brain volume (mm3) X 10,000. Based on the distribution, the normalized SI 
volumes were categorized into tertile groups; PD with the lowest SI volume (PD-L, n = 20), PD with an interme-
diate SI volume (n = 20), and PD with the highest SI volume (PD-H, n = 21).
Preprocessing of resting-state functional MRI data. Functional brain MRI analyses were performed following 
a previously described method37. Preprocessing of resting-state fMRI data was conducted using the Analysis of 
Functional NeuroImages, (http://afni.nimh.nih.gov/afni) software38. For stabilization of the magnetic field, the 
initial five volumes from each functional image were eliminated. The eliminated images were de-spiked, and then 
applied the slice timing and head motion corrections. At the motion-correction corrections, displacement owing 
to head motion effect was estimated using the head motion-correction parameters of the x, y, and z translations 
and the Yaw, Pitch and Roll rotation. For every subject, the estimated displacement due to head motion was sat-
isfied the condition: between successive time-series volumes <1 mm and any of the three translation directions 
<2 mm, or maximum rotation around any of the axes less than 2.0°. Then, the data were corrected using the 
anatomy-based correlation corrections method known as ANATICOR39. The ANATICOR is regression model for 
removing the not interest signal by the following: (1) six parameters acquired by correction of head motion, (2) 
signal from the eroded large ventricle mask, and (3) signal from the local white matter erosion mask (r = 15 mm). 
Subsequently, a band-pass filter (0.009 < f < 0.08) to remove physiological noise was temporally applied to the 
regressed data. The filtered data were masked out using the gray matter mask to remove the unwanted BOLD or 
other physiological signals occurring on account of large draining vessels. The spatial smoothing with Gaussian 
kernel of 6-mm full width at half maximum (FWHM) was conducted to the mask processed functional data. 
The spatial normalization to a standard MNI152 template was performed to the blurred functional data by the 
resampling with an isotropic voxel size of 2 mm. The head coil and hardware artifacts were modeled with signal 
from the eroded local white matter and signal from the eroded large ventricle masks. The white matter mask 
and large ventricle masks were classified from the registered and non-uniformity corrected T1-weighted images 
using an advanced neural-net classifier40 as well as non-linear warping algorithm41. For co-registration between 
the anatomical T1-weighted image and the functional echo planar image, the affine transform was used with 
Local Pearson Correlation cost function42. Also, all masks were transformed using by same transform matrix into 
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functional echo planar image space. The white matter mask and the large ventricle masks were eroded by one 
voxel to minimize the partial volume effects.
Functional connectivity analysis. To analyze functional connectivity, four ROIs were defined as the bilateral 
caudate, posterior cingulate cortex (PCC), and SI. First, the caudate was selected to exam functional connectivity 
between the basal ganglia and cerebral cortices43. The caudate was defined based on the automated anatomical 
labeling template44. Second, the PCC, which was highly associated with the default mode network (DMN) in 
the resting-state functional MRI analysis, was selected. The PCC has been widely described in recent years in 
PD20,45, because the network involving this region plays a key role in many cognitive functions such as memory, 
attention and problems maintaining the balance between internal and external thought46, which are important 
cognitive domains in PD. Additionally, it was the only node in the DMN that directly interacted with virtually all 
other nodes47. This region was described as a 6-mm radius sphere at the peak (x/y/z = 0/−52/30) using a voxel 
mask48, because this represents the main functional connectivity hub of the human49. The PCC ROI seed used 
for the DMN approach in the present study was based on the previous studies48–50. Finally, as the major source of 
cholinergic input to the cerebral cortex and an important neuroanatomical correlate for cognitive performance in 
PD, we selected the bilateral SI as a ROI. The time course for data in every ROI was averaged as reference signals. 
Then, the Pearson’s correlation coefficient was computed for each individual subject with averaged reference sig-
nals. The correlation coefficient was converted using Fisher’s z transformation.
Group comparisons. To assess the differences in functional connectivity among the PD-L, PD-H, and control 
groups, an analysis of covariance (ANCOVA) was employed using covariates as age and gender. In this stage, 
Monte Carlo simulations were performed to adjust for Type I errors (parameters: individual voxel P = 0.02, 
simulation = 10,000 times iteratively, 6-mm FWHM Gaussian filter width with a whole-brain mask) with the 
AlphaSim program, which provided an estimate of the overall significant level in the AFNI to determine a prob-
ability of the false positive detection from a frequency count of cluster size. This was achieved for a variety of 
probability thresholds combinations for each voxel and cluster size threshold. The corrected significant value was 
obtained as level of Pα < 0.05 (uncorrected individual voxel height threshold of P < 0.02, F > 4.157 with a min-
imum cluster size of 1,672 mm3). Afterward, significant areas determined by ANCOVA were applied to Post hoc 
two sample t-test between pairs of groups at Pα < 0.05 (corrected significant level).
Relationship between functional connectivity and SI value analysis. To investigate the association between resting 
state functional connectivity from the caudate or PCC seeds and the SI volume, a multiple regression analysis was 
performed in all PD subjects (n = 61) with age, gender, and education duration entered as covariates. The depend-
ent variable was z-scores of functional connectivity maps and the independent variable was normalized SI value. 
The statistical maps were corrected for multiple comparisons to a significance level of Pα < 0.05.
Relationship between functional connectivity and total cognitive composite score. A multiple regression analy-
sis was performed between total cognitive composite score and resting state functional connectivity from the 
caudate, PCC or SI seed in all PD subjects with age, gender, and education duration entered as covariates. The 
statistical values were same as above.
Image acquisition and quantitative analysis of the 18F-FP-CIT PET data. Quantitative analyses 
were performed following a modified version of a previously described procedure51. Image processing was per-
formed using SPM8 (Wellcome Department of Imaging Neuroscience, Institute of Neurology, UCL, London, 
UK) under Matlab 6.5.1 for Windows (Math Works, Natick, MA, USA) and MRIcro version 1.37 (Chris Rorden, 
Columbia, SC, USA). Quantitative analyses were based on the volumes of interest (VOIs), which were defined 
based on a template in the standard space. All reconstructed PET images were spatially normalized to the 
Talairach space using a standard 18F-FP-CIT PET template which was made using 18F-FP-CIT PET and T1 MR 
images of 13 normal controls to remove inter-subject anatomical variability. The VOIs of bilateral striatal subre-
gions and one occipital VOI were drawn on a co-registered spatially normalized single T1 MR and 18F-FP-CIT 
PET template image. The striatum was divided into the caudate, ventral striatum, anterior putamen, and posterior 
putamen. Dopamine transporter (DAT) activity was calculated by the non-displaceable binding potential, which 
was defined as follows: (mean standardized uptake value of the striatal subregion VOI – mean standardized 
uptake value of the occipital VOI)/mean standardized uptake value of the occipital VOI52. Of the VOIs, DAT 
activity in the posterior putamen was selected because this area is the most severely affected in early stage of PD53, 
and thus it likely reflects dopamine levels in the striata of individual patients.
Statistical analysis. All data are expressed as means (SDs). The analysis of variance test or the Chi Square 
test for continuous and categorical variables, respectively. Post hoc analyses were performed using a Bonferroni 
test to correct for multiple comparisons. Statistical analyses were performed using commercially available soft-
ware (SPSS, ver.20.0), and a two tailed P < 0.05 was considered significant.
Ethical approval. This study was approved by the Yonsei University Severance Hospital ethical standards 
committee on human experimentation for experiments using human subjects and was therefore performed in 
accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Informed consent. Because this study was a retrospective analysis of medical data, we were not required to 
obtain patient consent.
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